Bausch Health Companies Inc. Repayments of Long-Term Debt
Bausch Health Companies Inc. (BHC) reported Repayments of Long-Term Debt of $2.97 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-07-30
- Bausch Health Companies Inc. repayments of long-term debt for the quarter ending 2026-06-30 was $112.00M, a 98.88% decline year-over-year.
- Bausch Health Companies Inc. repayments of long-term debt for the quarter ending 2026-03-31 was $2.86B, a 1600.60% increase year-over-year.
- Bausch Health Companies Inc. repayments of long-term debt for the quarter ending 2025-12-31 was $352.00M, a 14.36% decline year-over-year.
- Bausch Health Companies Inc. repayments of long-term debt for the quarter ending 2025-09-30 was $704.00M, a 329.27% increase year-over-year.
- Bausch Health Companies Inc. repayments of long-term debt for fiscal 2025 was $11.19B, a 666.51% increase from fiscal 2024.
- Bausch Health Companies Inc. repayments of long-term debt for fiscal 2024 was $1.46B, a 14.62% decline from fiscal 2023.
- Bausch Health Companies Inc. repayments of long-term debt for fiscal 2023 was $1.71B, a 78.21% decline from fiscal 2022.
- Bausch Health Companies Inc. repayments of long-term debt for fiscal 2022 was $7.85B, a 128.08% increase from fiscal 2021.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 3 month as first filed | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 6 month as first filed | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 9 month as first filed | Repayments of Long-term Debt 12 month | Repayments of Long-term Debt 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $112.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $2.97B 10-Q · filed 2026-07-30 | $3.32B derived: sum of 3 quarters · filed 2026-07-30 | $4.03B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $2.86B 10-Q · filed 2026-04-30 | $3.21B derived: sum of 2 quarters · filed 2026-04-30 | $3.91B derived: sum of 3 quarters · filed 2026-04-30 | $13.88B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $352.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $1.06B derived: sum of 2 quarters · filed 2026-02-19 | $11.02B derived: sum of 3 quarters · filed 2026-07-30 | $11.19B 10-K · filed 2026-02-19 | ||||
| 2025-09-30 | $704.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $10.67B derived: sum of 2 quarters · filed 2026-07-30 | $10.84B 10-Q · filed 2025-10-30 | $11.25B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $9.97B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $10.13B 10-Q · filed 2026-07-30 | $10.55B derived: sum of 3 quarters · filed 2026-07-30 | $10.71B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $168.00M 10-Q · filed 2026-04-30 | $579.00M derived: sum of 2 quarters · filed 2026-04-30 | $743.00M derived: sum of 3 quarters · filed 2026-04-30 | $1.24B derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | $411.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $575.00M derived: sum of 2 quarters · filed 2026-02-19 | $1.07B derived: sum of 3 quarters · filed 2026-02-19 | $1.46B 10-K · filed 2026-02-19 | ||||
| 2024-09-30 | $164.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $659.00M derived: sum of 2 quarters · filed 2025-10-30 | $1.05B 10-Q · filed 2025-10-30 | $1.25B derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-06-30 | $495.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $885.00M 10-Q · filed 2025-07-31 | $1.09B derived: sum of 3 quarters · filed 2026-02-19 | $1.91B derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-03-31 | $390.00M 10-Q · filed 2025-05-01 | $593.00M derived: sum of 2 quarters · filed 2026-02-19 | $1.41B derived: sum of 3 quarters · filed 2026-02-19 | $1.82B derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2023-12-31 | $203.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $1.02B derived: sum of 2 quarters · filed 2026-02-19 | $1.43B derived: sum of 3 quarters · filed 2026-02-19 | $1.71B 10-K · filed 2026-02-19 | ||||
| 2023-09-30 | $817.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $1.23B derived: sum of 2 quarters · filed 2024-10-31 | $1.51B 10-Q · filed 2024-10-31 | $2.13B derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-06-30 | $411.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $690.00M 10-Q · filed 2024-08-01 | $1.31B derived: sum of 3 quarters · filed 2025-02-20 | $1.45B derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-03-31 | $279.00M 10-Q · filed 2024-05-02 | $901.00M derived: sum of 2 quarters · filed 2025-02-20 | $1.04B derived: sum of 3 quarters · filed 2025-02-20 | $7.64B derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2022-12-31 | $622.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $763.00M derived: sum of 2 quarters · filed 2025-02-20 | $7.36B derived: sum of 3 quarters · filed 2025-02-20 | $7.85B 10-K · filed 2025-02-20 | ||||
| 2022-09-30 | $141.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $6.74B derived: sum of 2 quarters · filed 2023-11-02 | $7.22B 10-Q · filed 2023-11-02 | $7.46B derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-06-30 | $6.60B derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $7.08B 10-Q · filed 2023-08-03 | $7.32B derived: sum of 3 quarters · filed 2024-02-22 | $8.42B derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-03-31 | $485.00M 10-Q · filed 2023-05-04 | $725.00M derived: sum of 2 quarters · filed 2024-02-22 | $1.82B derived: sum of 3 quarters · filed 2024-02-22 | $3.73B derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | $240.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $1.34B derived: sum of 2 quarters · filed 2024-02-22 | $3.24B derived: sum of 3 quarters · filed 2024-02-22 | $3.44B 10-K · filed 2024-02-22 | ||||
| 2021-09-30 | $1.10B derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $3.00B derived: sum of 2 quarters · filed 2022-11-03 | $3.20B 10-Q · filed 2022-11-03 | $5.68B derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-30 | $1.90B derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $2.10B 10-Q · filed 2022-08-09 | $4.58B derived: sum of 3 quarters · filed 2023-02-23 | $4.68B derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-31 | $200.00M 10-Q · filed 2022-05-10 | $2.68B derived: sum of 2 quarters · filed 2023-02-23 | $2.78B derived: sum of 3 quarters · filed 2023-02-23 | $4.38B derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | $2.48B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $2.58B derived: sum of 2 quarters · filed 2023-02-23 | $4.18B derived: sum of 3 quarters · filed 2023-02-23 | $5.64B 10-K · filed 2023-02-23 | ||||
| 2020-09-30 | $100.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $1.70B derived: sum of 2 quarters · filed 2021-11-02 | $3.16B 10-Q · filed 2021-11-02 | $3.61B derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-06-30 | $1.60B derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $3.06B 10-Q · filed 2021-08-03 | $3.51B derived: sum of 3 quarters · filed 2022-05-11 | $3.96B derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-03-31 | $1.46B 10-Q · filed 2021-05-04 | $1.91B derived: sum of 2 quarters · filed 2022-05-11 | $2.36B derived: sum of 3 quarters · filed 2022-05-11 | $4.24B derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2019-12-31 | $450.00M derived: 8-K 12 month − 10-Q 9 month · filed 2022-05-11 | $903.00M derived: sum of 2 quarters · filed 2022-05-11 | $2.79B derived: sum of 3 quarters · filed 2022-05-11 | $4.41B 8-K · filed 2022-05-11 | ||||
| 2019-09-30 | $453.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | $2.33B derived: sum of 2 quarters · filed 2020-11-03 | $3.96B 10-Q · filed 2020-11-03 | $5.86B derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-06-30 | $1.88B derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $3.50B 10-Q · filed 2020-08-06 | $5.40B derived: sum of 3 quarters · filed 2021-05-04 | $5.77B derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-03-31 | $1.62B 10-Q · filed 2020-05-07 | $3.52B derived: sum of 2 quarters · filed 2021-05-04 | $3.89B derived: sum of 3 quarters · filed 2021-05-04 | $9.99B derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2018-12-31 | $1.90B derived: 8-K 12 month − 10-Q 9 month · filed 2021-05-04 | $2.27B derived: sum of 2 quarters · filed 2021-05-04 | $8.37B derived: sum of 3 quarters · filed 2021-05-04 | $10.10B 8-K · filed 2021-05-04 | ||||
| 2018-09-30 | $364.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $6.47B derived: sum of 2 quarters · filed 2019-11-04 | $8.20B 10-Q · filed 2019-11-04 | $13.15B derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-06-30 | $6.11B derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $7.84B 10-Q · filed 2019-08-06 | $12.79B derived: sum of 3 quarters · filed 2020-02-19 | $14.20B derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-03-31 | $1.73B 10-Q · filed 2019-05-06 | $6.68B derived: sum of 2 quarters · filed 2020-02-19 | $8.10B derived: sum of 3 quarters · filed 2020-02-19 | $8.31B derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2017-12-31 | $4.95B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $6.36B derived: sum of 2 quarters · filed 2020-02-19 | $6.58B derived: sum of 3 quarters · filed 2020-02-19 | $14.20B 10-K · filed 2020-02-19 | ||||
| 2017-09-30 | $1.41B derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $1.63B derived: sum of 2 quarters · filed 2018-11-06 | $9.25B 10-Q · filed 2018-11-06 | $9.77B derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-06-30 | $220.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $7.84B 10-Q · filed 2018-08-07 | $8.36B derived: sum of 3 quarters · filed 2019-02-20 | $9.00B derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-03-31 | $7.62B 10-Q · filed 2018-05-08 | $8.14B derived: sum of 2 quarters · filed 2019-02-20 | $8.78B derived: sum of 3 quarters · filed 2019-02-20 | $9.63B derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2016-12-31 | $519.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $1.16B derived: sum of 2 quarters · filed 2019-02-20 | $2.01B derived: sum of 3 quarters · filed 2019-02-20 | $2.44B 10-K · filed 2019-02-20 | ||||
| 2016-09-30 | $644.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $1.49B derived: sum of 2 quarters · filed 2017-11-07 | $1.92B 10-Q · filed 2017-11-07 | $1.92B 10-Q · filed 2016-11-09 | $2.58B derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2016-06-30 | $847.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $1.27B 10-Q · filed 2017-08-08 | $1.27B 10-Q · filed 2016-08-09 | $1.94B derived: sum of 3 quarters · filed 2018-08-10 | $1.97B derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2016-03-31 | $426.00M 10-Q · filed 2017-05-09 | $425.60M 10-Q · filed 2016-06-07 | $1.09B derived: sum of 2 quarters · filed 2018-08-10 | $1.12B derived: sum of 3 quarters · filed 2018-08-10 | $1.37B derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2015-12-31 | $667.80M derived: 8-K 12 month − 10-Q 9 month · filed 2018-08-10 | $696.80M derived: sum of 2 quarters · filed 2018-08-10 | $944.70M derived: sum of 3 quarters · filed 2018-08-10 | $2.06B 8-K · filed 2018-08-10 | $2.06B 10-K · filed 2016-04-29 | |||
| 2015-09-30 | $29.00M 10-Q · filed 2015-10-26 | $276.90M derived: sum of 2 quarters · filed 2015-10-26 | $1.39B 10-Q · filed 2016-11-09 | $3.09B derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | $247.90M 10-Q · filed 2015-07-28 | $1.36B 10-Q · filed 2016-08-09 | $3.06B derived: sum of 3 quarters · filed 2017-03-01 | $4.69B derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | $1.11B 10-Q · filed 2016-06-07 | $2.81B derived: sum of 2 quarters · filed 2017-03-01 | $4.44B derived: sum of 3 quarters · filed 2017-03-01 | $4.56B derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | $1.70B derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $3.33B derived: sum of 2 quarters · filed 2017-03-01 | $3.45B derived: sum of 3 quarters · filed 2017-03-01 | $3.89B 10-K · filed 2017-03-01 | ||||
| 2014-09-30 | $1.63B 10-Q · filed 2015-10-26 | $1.75B derived: sum of 2 quarters · filed 2015-10-26 | $2.18B 10-Q · filed 2015-10-26 | $3.12B derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-06-30 | $120.30M 10-Q · filed 2015-07-28 | $554.20M 10-Q · filed 2015-07-28 | $1.49B derived: sum of 3 quarters · filed 2016-04-29 | $6.28B derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-03-31 | $433.90M 10-Q · filed 2015-04-30 | $1.37B derived: sum of 2 quarters · filed 2016-04-29 | $6.16B derived: sum of 3 quarters · filed 2016-04-29 | $6.33B derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2013-12-31 | $940.40M derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | $5.72B derived: sum of 2 quarters · filed 2016-04-29 | $5.90B derived: sum of 3 quarters · filed 2016-04-29 | $6.33B 10-K · filed 2016-04-29 | $6.33B 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $4.78B 10-Q · filed 2014-10-24 | $4.78B 10-Q · filed 2013-11-01 | $4.96B derived: sum of 2 quarters · filed 2014-10-24 | $5.39B 10-Q · filed 2014-10-24 | $5.39B 10-Q · filed 2013-11-01 | $6.85B derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-06-30 | $174.70M 10-Q · filed 2014-08-01 | $174.71M 10-Q · filed 2013-08-07 | $604.70M 10-Q · filed 2014-08-01 | $604.74M 10-Q · filed 2013-08-07 | $2.07B derived: sum of 3 quarters · filed 2015-02-25 | $2.10B derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-03-31 | $430.00M 10-Q · filed 2014-05-09 | $430.04M 10-Q · filed 2013-05-03 | $1.90B derived: sum of 2 quarters · filed 2015-02-25 | $1.93B derived: sum of 3 quarters · filed 2015-02-25 | $2.06B derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2012-12-31 | $1.47B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $1.50B derived: sum of 2 quarters · filed 2015-02-25 | $1.63B derived: sum of 3 quarters · filed 2015-02-25 | $1.93B 10-K · filed 2015-02-25 | $1.93B 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $31.06M 10-Q · filed 2013-11-01 | $158.24M derived: sum of 2 quarters · filed 2013-11-01 | $461.06M 10-Q · filed 2013-11-01 | $1.48B derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-06-30 | $127.18M 10-Q · filed 2013-08-07 | $429.99M 10-Q · filed 2013-08-07 | $1.45B derived: sum of 3 quarters · filed 2014-02-28 | $1.46B derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-03-31 | $302.81M 10-Q · filed 2013-05-03 | $1.32B derived: sum of 2 quarters · filed 2014-02-28 | $1.33B derived: sum of 3 quarters · filed 2014-02-28 | $1.33B derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | $1.02B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $1.03B derived: sum of 2 quarters · filed 2014-02-28 | $1.03B derived: sum of 3 quarters · filed 2014-02-28 | $2.00B 10-K · filed 2014-02-28 | ||||
| 2011-09-30 | $11.09M 10-Q · filed 2012-11-05 | $11.09M derived: sum of 2 quarters · filed 2012-11-05 | $986.09M 10-Q · filed 2012-11-05 | $1.51B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $975.00M 10-Q · filed 2012-08-03 | $1.50B derived: sum of 3 quarters · filed 2013-02-28 | $1.50B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | $975.00M 10-Q · filed 2012-05-04 | $1.50B derived: sum of 2 quarters · filed 2013-02-28 | $1.50B derived: sum of 3 quarters · filed 2013-02-28 | $1.51B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $525.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $525.00M derived: sum of 2 quarters · filed 2013-02-28 | $537.50M derived: sum of 3 quarters · filed 2013-02-28 | $537.50M 10-K · filed 2013-02-28 | ||||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $12.50M derived: sum of 2 quarters · filed 2011-11-04 | $12.50M 10-Q · filed 2011-11-04 | |||||
| 2010-06-30 | $12.50M 10-Q · filed 2011-08-08 | $12.50M 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |